TARGETED MOLECULAR DIAGNOSTICS
TARGETED MOLECULAR DIAGNOSTICS
Industry:
Clinical Trials Health Care Health Diagnostics Medical
Founded:
2004-01-01
Status:
Active
Contact:
(630)789-1233
Similar Organizations
Gema
Gema Diagnostics is a molecular diagnostics company.
Hype Medical
HYPE Medical is clinic management company
Portland Leadership Institute
Portland Leadership Institute is a Medical company.
Predicant Biosciences
cancer diagnostic startup using protein biomarker signatures in blood
The Banks Group LLC
The Banks Group LLC is a Clinical Trials company.
The Green Door
Largest Cannabis Dispensary in San Francisco
The Low T Center
Low Testosterone Diagnosis and Treatment Company
More informations about "Targeted Molecular Diagnostics"
TARGETED MOLECULAR DIAGNOSTICS, LLC - NPI 1518959741
Aug 15, 2005 This page provides the complete NPI Profile along with additional information for Targeted Molecular Diagnostics, Llc, a provider established in Westmont, ... TARGETED …See details»
Targeted Molecular Diagnostics - Crunchbase
983 Number of Organizations • $41.9B Total Funding Amount • 2,216 Number of Investors. Track . ... Who are Targeted Molecular Diagnostics 's competitors? Alternatives and possible …See details»
Targeted Molecular Diagnostics - PitchBook
Sep 8, 2011 Targeted Molecular Diagnostics General Information Description. Operator of diagnostics laboratory services on oncology and serves the drug development process. The …See details»
WHO launches new guidance on the use of targeted …
Mar 20, 2024 The World Health Organization (WHO) has just published recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant …See details»
Targeted Molecular Diagnostics - Overview, News & Similar
Nov 13, 2022 Who is Targeted Molecular Diagnostics. Targeted Molecular Diagnostics LLC is a company that operates in the Biotechnology industry. It employs 11-20 people and has $0M …See details»
TARGETED MOLECULAR DIAGNOSTICS, LLC - HIPAASpace
The 1518959741 NPI number is assigned to the healthcare provider TARGETED MOLECULAR DIAGNOSTICS, LLC, practice location address at 610 OAKMONT LN WESTMONT, IL, 60559 …See details»
Targeted Molecular Diagnostics LLC - Drug pipelines, Patents, …
Explore Targeted Molecular Diagnostics LLC with its drug pipeline, therapeutic area, technology platform, 2 literature, Technology Platform:Small molecule drug, Drug:GW-974. Products. …See details»
MolecularMD - Crunchbase Company Profile & Funding
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly …See details»
Targeted Molecular Diagnostics - Tech Stack, Apps, Patents
Targeted Molecular Diagnostics is a Clinical Trials company. Experience the new Crunchbase, powered by AISee details»
TARGETED MOLECULAR DIAGNOSTICS, LLC; NPI #1518959741
TARGETED MOLECULAR DIAGNOSTICS, LLC Clinical Medical Laboratory (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, …See details»
Targeted Molecular Diagnostics - Contract Research Map
610 Oakmont Lane Westmont IL 60559 USA Targeted Molecular Diagnostics provides safety testing, biomarkers, ... It was created to help researchers in the life sciences identify and …See details»
Molecular diagnostics - Nature Reviews Drug Discovery
Molecular diagnostics are increasingly being developed to help guide treatment choice of targeted therapies, as well as to help optimize treatment outcomes and reduce the risk of serious …See details»
Target product profiles - FIND
Antimicrobial resistance; Need: Target product profile: Diagnostics to detect antibacterial resistance: Due to the increasing prevalence of antimicrobial resistance, there is a need to …See details»
Leading Medical Organizations Update Guideline for Molecular
Jan 22, 2018 The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ …See details»
Molecular diagnostics tailoring personalized cancer therapy—an ...
Advances in molecular diagnostics and the biologic understanding of cancer pathophysiology led to the identification of specific genetic alterations as drivers of cancer progression. Further, …See details»
Technologies in molecular diagnostics: what’s new? - Cytiva
Apr 3, 2024 Read how molecular diagnostics and personalized medicine is advancing with the use of mass ... and genetics, advances in molecular diagnostics are paving the way for earlier …See details»
Molecular diagnostic tools for the World Health Organization …
Jun 2, 2023 Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline ... (select …See details»
Leveraging Molecular Diagnostic Technologies to Close the Global …
Oct 17, 2022 Organizations such as the Foundation of Innovative New Diagnostics can work with industry partners (through initiatives such as Access Accelerated) to negotiate purchasing …See details»
NCI-Molecular Analysis for Therapy Choice (MATCH) Trial Network
Apr 22, 2025 About NCI-MATCH. The NCI-MATCH Trial Network was launched in 2015. Although the original MATCH closed in 2023, it shepherded a new generation of precision …See details»
Pyrazinamide-resistant Tuberculosis Obscured From Common …
May 1, 2023 Thus, current molecular PZA susceptibility diagnostics (targeted Sanger sequencing), a Line Probe Assay (LPA) recently endorsed by the WHO (World Health …See details»